APO 150 (Nizatidine 150 mg)

Pill imprint APO 150 has been identified as Nizatidine 150 mg.

Nizatidine is used in the treatment of gerd; indigestion; erosive esophagitis; duodenal ulcer; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO 150

Nizatidine 150 mg APO 150
Nizatidine 150 mg APO 150
Nizatidine
Imprint:
APO
150
Strength:
150 mg
Color:
White & Yellow
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0230
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose monohydrate
stearic acid
magnesium silicate
gelatin
titanium dioxide
ferric oxide yellow
ammonia
alcohol
isopropyl alcohol
butyl alcohol
potassium hydroxide
propylene glycol
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55045-3748 Dispensing Solutions Inc. (repackager)
55887-0153 Diversified Healthcare Services Inc (repackager)
23490-6010 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)